Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma

NCT03757221 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
55
Enrollment
OTHER
Sponsor class

Stopped Early termination (regarding the follow-up of the patients). The required sample size was reached, and the primary endpoint was met.

Conditions

Interventions

Sponsor

University Hospital, Caen